Trial of Late Surfactant for Prevention of Bronchopulmonary Dysplasia

Completed · Phase 3 · Has a placebo group

Conditions studied: Bronchopulmonary Dysplasia

In brief

The purpose of this study is to determine if late doses of Infasurf surfactant given when patients are receiving inhaled nitric oxide will interact to improve surfactant function and increase survival without BPD in treated infants.

Key facts

Study ID
NCT01022580
Run by
Roberta Ballard
People needed
511
Starts
2010-01-01
Expected to finish
2016-01-01
Last updated by the study team
2021-05-13

Who can join

Age: 0 and older, up to 0. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.